Start Resolution | Procedure (no.) | Brand name | Pharm. company | Therapeutic area | Indication |
---|---|---|---|---|---|
Brentuximab Vedotin (7) (ausgesetzt) | Adcetris® | Takeda GmbH | Oncological diseases | Hodgkin-Lymphoma (CD30+, first-line, stadium III, in combination with Doxorubicin, Vinblastin and Dacarbazin) (Orphan) | |
Onasemnogen-Abeparvovec (ausgesetzt) | Zolgensma® | AveXis | Nervous system diseases | Spinal muscular atrophy (SMA) (Orphan) |